SHOM to Expand Research onto Precision Medicine

Biotech Investing

Southern Home Medical Inc. (OTC PINK: SHOM), a leading developer of the healthcare industry, has announced that it will be expanding research and market onto Precision Medicine with cooperation and assistance from Dr. Zhongzheng Liu and President Obama’s support via the “Precision Medicine Initiative”. By promoting the use of personalized genetic information in the treatment …

Southern Home Medical Inc. (OTC PINK: SHOM), a leading developer of the healthcare industry, has announced that it will be expanding research and market onto Precision Medicine with cooperation and assistance from Dr. Zhongzheng Liu and President Obama’s support via the “Precision Medicine Initiative”. By promoting the use of personalized genetic information in the treatment of human diseases, breakthroughs in medical development can be achieved. SHOM will be diving headfirst into the market of Precision Medicine which is modeled to create $607 billion in health benefits.
Precision Medicine therapy is developed for the individual characteristics of each individual patient and is developed and designed based on the patient’s susceptibility to specific diseases. The patient can be targeted for long-range treatment in the future, and individual characteristics can be identified at high risk. In addition, there is estimated to be a 10% reduction in instances of diabetes and cancer In the future, the YS government will invest 215 million US dollars to promote the program. SHOM will take the initiative forward and invest research into precision medicine in order to better its services and expand its market.
George Chang, Chief Executive Officer of SHOM, commented, “With support from the US Government, it will be a lot easier to expand and research into the area of precision medicine. Precision medicine and its potential capabilities are very exciting and by applying this to our existing technologies, these capabilities will be further amplified. We can expect major growth in the company as a result of the massive support that the area of precision medicine is getting.”
About Biotech Precision Berhad: Biotech Precision Berhad (BPB) delivers luxuriously affordable and effective individualized beauty, wellness and healthcare therapy by using scientifically proven products and techniques to clients with degenerative diseases. The ultimate goal for BPB is to make beauty, wellness and healthcare a priority in the life of each guest. BPB’s greatest desire is that with each visit, guests will discover a healthier and radiant person within themselves.
About Southern Home Medical, Inc.: Southern Home Medical, Inc. is a Holding Company with a focus on servicing the needs of the Healthcare Industry. SHOM will continue to leverage the success of their businesses in order to expand sales opportunities in other locations throughout the country with health, medical and equipment needs.
Websites:
www.southernhomemedical.com
https://twitter.com/southernhomemed
https://www.facebook.com/southernhomemedical
Forward-Looking Statements
This press release contains forward-looking statements related to Southern Home Medical, CES Technology Ltd., and KC Global Inc., and the potential benefits of the acquisition, including statements regarding timing of closing and results of the proposed transaction. Actual events or results may differ materially from those contained in the forward-looking statements due to risks, uncertainties and assumptions. These risks and uncertainties include, but are not limited to, risks associated with: Southern Home Medical’s ability to successfully integrate CES Technology Ltd.; execution of plans and strategies; the inability to successfully complete the transaction, and other important factors that could cause results of the acquisition and related transactions to differ materially from the forward-looking statements detailed in Southern Home Medical’s public filings with OTC Markets and the SEC, including its most recent Annual Report. Southern Home Medical disclaims any obligation to update any forward-looking or other statements in this release, except as required by law.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 relating to Southern Home Medical operations, results of operations and other matters that are based on SHOM’s current expectations, estimates, forecasts and projections. Words, such as “anticipate,” “believe,” “could,” “expect,” “estimate,” “intend,” “may,” “opportunity,” “plan,” “positioned,” “potential,” “project,” “should,” and “will” and similar expressions, are intended to identify these forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Forward-looking statements are based on assumptions as to future events that may not prove to be accurate. Readers are cautioned not to put undue reliance on forward-looking statements.

US CONTACT INFO:
Southern Home Medical Inc. (SHOM)
NEWS RELEASE DEPARTMENT
646-206-5353

The Conversation (0)
×